Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,298 | -43,454 | -21,320 | -86,650 | -16,780 |
| Depreciation Amortization | 3,174 | 2,182 | 958 | 1,770 | 120 |
| Accounts payable and accrued liabilities | 318 | -446 | -718 | N/A | N/A |
| Other Working Capital | 872 | 3,070 | 788 | 4,280 | 420 |
| Other Operating Activity | 2,635 | 2,270 | 1,483 | 8,250 | 1,190 |
| Operating Cash Flow | $-58,299 | $-36,378 | $-18,809 | $-72,350 | $-15,050 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,804 | -1,437 | -868 | -6,130 | -3,060 |
| Purchase Of Investment | -46,651 | -28,156 | -16,949 | N/A | N/A |
| Sale Of Investment | 102,438 | 67,050 | 33,200 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -212,870 | 0 |
| Investing Cash Flow | $53,983 | $37,457 | $15,383 | $-219,000 | $-3,060 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 732 | 375 | 324 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 300,470 | 48,850 |
| Financing Cash Flow | $732 | $375 | $324 | $300,470 | $48,850 |
| Beginning Cash Position | 40,388 | 40,388 | 40,388 | 30,740 | 0 |
| End Cash Position | 36,804 | 41,842 | 37,286 | 39,850 | 30,740 |
| Net Cash Flow | $-3,584 | $1,454 | $-3,102 | $9,110 | $30,740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,299 | -36,378 | -18,809 | -72,350 | -15,050 |
| Capital Expenditure | -1,804 | -1,437 | -868 | N/A | N/A |
| Free Cash Flow | -60,103 | -37,815 | -19,677 | -72,350 | -15,050 |